CEFOTETAN (cefotetan) by Hikma is clinical pharmacology high plasma levels of cefotetan are attained after intravenous and intramuscular administration of single doses to normal volunteers. Approved for cephalosporin antibacterial [epc]. First approved in 2011.
Drug data last refreshed 22h ago
CLINICAL PHARMACOLOGY High plasma levels of cefotetan are attained after intravenous and intramuscular administration of single doses to normal volunteers. PLASMA CONCENTRATIONS AFTER 1 GRAM IV OR IM DOSE Mean Plasma Concentration (mcg/mL) Time After Injection Route 15 min 30 min 1 h 2 h 4 h 8 h 12…
Worked on CEFOTETAN at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Cephalosporin Antibacterial
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Cefotetan Therapy for Escherichia Coli Infections